Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase II contract was awarded to Integrated Biotherapeutics, Inc. in July, 2019 for $999,997.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42AI122666-03 | Phase II | 999,997 | July 5, 2019 | |||||||
A STTR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in July, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI147929-01 | Phase I | 300,000 | July 12, 2019 | |||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in April, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI145480-01 | Phase I | 300,000 | April 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in April, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI136143-01A1 | Phase I | 300,000 | April 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Integrated Biotherapeutics, Inc. in April, 2021 for $804,193.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI140932-02 | Phase II | 804,193 | April 8, 2021 | |||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in March, 2019 for $290,038.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI140932-01A1 | Phase I | 290,038 | March 14, 2019 | |||||||
A SBIR Phase II contract was awarded to Integrated Biotherapeutics, Inc. in May, 2021 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI155309-01A1 | Phase II | 1,000,000 | May 12, 2021 | |||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in January, 2018 for $601,655.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI136229-01 | Phase I | 601,655 | January 26, 2018 | |||||||
A STTR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in July, 2020 for $299,939.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI152745-01A1 | Phase I | 299,939 | July 6, 2020 | |||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in June, 2014 for $599,996.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI106162-01A1 | Phase I | 599,996 | June 15, 2014 | |||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in February, 2015 for $230,063.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI113959-01A1 | Phase I | 230,063 | February 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Integrated Biotherapeutics, Inc. in January, 2009 for $1,159,390.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-08-C-0004 | Phase II | 1,159,390 | January 15, 2009 | |||||||
A STTR Phase II contract was awarded to Integrated Biotherapeutics, Inc. in July, 2017 for $1,861,259.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42AI122403-02 | Phase II | 1,861,259 | July 1, 2017 | |||||||
A STTR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in February, 2017 for $594,931.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI122666-01A1 | Phase I | 594,931 | February 15, 2017 | |||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in July, 2016 for $284,365.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI124765-01A1 | Phase I | 284,365 | July 1, 2016 | |||||||
A STTR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in July, 2016 for $229,991.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI122403-01 | Phase I | 229,991 | July 5, 2016 | |||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in February, 2017 for $438,765.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI129218-01 | Phase I | 438,765 | February 10, 2017 | |||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in October, 2007 for $109,774.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-08-C-0004 | Phase I | 109,774 | October 19, 2007 | |||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $600,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI094829-01 | Phase I | 600,000 | ||||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $593,316.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI100414-01A1 | Phase I | 593,316 | ||||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $600,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI085665-01 | Phase I | 600,000 | ||||||||
A STTR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $600,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI108024-01 | Phase I | 600,000 | ||||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $590,778.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI098232-01 | Phase I | 590,778 | ||||||||
A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $550,414.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI098178-01A1 | Phase I | 550,414 |